Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gas… (NCT07324785) | Clinical Trial Compass
RecruitingNot Applicable
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
China50 participantsStarted 2026-01-07
Plain-language summary
This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis（DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for diabetes gastroparesis group:
* Meet the diagnostic criteria for diabetes
* Presence of symptoms (see assessment of Gastroparesis Cardinal Symptom Index)
* Age range from 18 to 75 years old
* Voluntarily participate and sign an informed consent form
Inclusion Criteria for control group:
* No history of diabetes
* No symptoms (see assessment of Gastroparesis Cardinal Symptom Index)
* Age range from 18 to 75 years old
* Voluntarily participate and sign an informed consent form
Exclusion Criteria for diabetes gastroparesis group and control group:
* Currently taking prokinetic drugs, anticholinergic drugs, and dopamine drugs that may affect gastric motility
* Has a history of gastrointestinal surgery
* Pregnant or preparing to conceive
* There are neurological disorders such as Parkinson's disease that affect gastrointestinal function
* Outlet obstruction caused by organic lesions in the pylorus
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Gastroparesis Cardinal Symptom Index (GCSI) score
Timeframe: The day when the subjects were enrolled